Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-05-08 00:00:00 ET · period of report 2023-04-28 · accession 0001209191-23-027934 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | 2023-04-28 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $66.88 | +239 | 49.7K | +0.5% | +$16.0K | |
| 2023-05-08 | 2023-05-04 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $95.45 | -4,302 | 45.4K | -9% | -$410.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | A | A | 239 | $66.88 | 49,703 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-05-04 | F | D | 4,302 | $95.45 | 45,401 | D | — | — |